Do analysts recommend SKLZ or ONMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Skillz 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, SKLZ or ONMD?

OneMedNet has lower revenue, but higher earnings than Skillz. OneMedNet is trading at a lower price-to-earnings ratio than Skillz, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Skillz $104.50M 1.33 -$70.41M -$3.48 N/A OneMedNet $1.36M 29.83 -$2.80M -$0.05 N/A

Is SKLZ or ONMD more profitable?

Skillz has a net margin of -48.49% compared to OneMedNet's net margin of -254.13%. OneMedNet's return on equity of 0.00% beat Skillz's return on equity. Company Net Margins Return on Equity Return on Assets Skillz -48.49% -52.81% -20.87% OneMedNet -254.13% N/A -383.90%

Do analysts rate RGP or ONMD?

Resources Connection currently has a consensus price target of $7.00, indicating a potential upside of 52.51%. Given Resources Connection's stronger consensus rating and higher possible upside, research analysts clearly believe Resources Connection is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Resources Connection 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer RGP or ONMD?

In the previous week, Resources Connection had 8 more articles in the media than OneMedNet. MarketBeat recorded 10 mentions for Resources Connection and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.95 beat Resources Connection's score of -0.18 indicating that OneMedNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Resources Connection 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ONMD or OPRX?

OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 96.04%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts clearly believe OptimizeRx is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 OptimizeRx 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.56

Which has stronger valuation & earnings, ONMD or OPRX?

OptimizeRx has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OneMedNet $1.36M 29.83 -$2.80M -$0.05 N/A OptimizeRx $109.43M 1.17 $5.13M $0.35 19.57

Is ONMD or OPRX more profitable?

OptimizeRx has a net margin of 6.37% compared to OneMedNet's net margin of -254.13%. OptimizeRx's return on equity of 10.86% beat OneMedNet's return on equity. Company Net Margins Return on Equity Return on Assets OneMedNet -254.13% N/A -383.90% OptimizeRx 6.37% 10.86% 7.93%

Does the media refer more to ONMD or OPRX?

In the previous week, OptimizeRx had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.95 beat OptimizeRx's score of 0.52 indicating that OneMedNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate SCOR or ONMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score comScore 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SCOR or ONMD more profitable?

comScore has a net margin of 24.81% compared to OneMedNet's net margin of -254.13%. comScore's return on equity of 230.75% beat OneMedNet's return on equity. Company Net Margins Return on Equity Return on Assets comScore 24.81% 230.75% 23.84% OneMedNet -254.13% N/A -383.90%

Does the media prefer SCOR or ONMD?

In the previous week, comScore and comScore both had 2 articles in the media. OneMedNet's average media sentiment score of 0.95 beat comScore's score of 0.06 indicating that OneMedNet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment comScore 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OneMedNet 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ONMD or MXCT?

MaxCyte has a consensus target price of $5.00, suggesting a potential upside of 350.45%. Given MaxCyte's stronger consensus rating and higher probable upside, analysts plainly believe MaxCyte is more favorable than OneMedNet. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OneMedNet 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 MaxCyte 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is ONMD or MXCT more profitable?

MaxCyte has a net margin of -121.16% compared to OneMedNet's net margin of -254.13%. OneMedNet's return on equity of 0.00% beat MaxCyte's return on equity. Company Net Margins Return on Equity Return on Assets OneMedNet -254.13% N/A -383.90% MaxCyte -121.16% -20.03% -17.14%

OneMedNet (ONMD) Competitors

$0.71 -0.05 (-6.16%)

Closing price 04:00 PM Eastern

Extended Trading

$0.71 +0.00 (+0.22%)

As of 07:34 PM Eastern

Compare

ONMD vs. SKLZ, RGP, OPRX, SCOR, and MXCT

Should you buy OneMedNet stock or one of its competitors? MarketBeat compares OneMedNet with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OneMedNet include Skillz (SKLZ), Resources Connection (RGP), OptimizeRx (OPRX), comScore (SCOR), and MaxCyte (MXCT).

How does OneMedNet compare to Skillz?

Skillz (NYSE:SKLZ) and OneMedNet (NASDAQ:ONMD) are related small-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Skillz	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, OneMedNet had 2 more articles in the media than Skillz. MarketBeat recorded 2 mentions for OneMedNet and 0 mentions for Skillz. OneMedNet's average media sentiment score of 0.95 beat Skillz's score of 0.00 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Overall Sentiment
Skillz	Neutral
OneMedNet	Positive

Skillz has a net margin of -48.49% compared to OneMedNet's net margin of -254.13%. OneMedNet's return on equity of 0.00% beat Skillz's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Skillz	-48.49%	-52.81%	-20.87%
OneMedNet	-254.13%	N/A	-383.90%

19.4% of Skillz shares are owned by institutional investors. Comparatively, 1.0% of OneMedNet shares are owned by institutional investors. 59.4% of Skillz shares are owned by insiders. Comparatively, 46.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Skillz has a beta of 4.58, indicating that its stock price is 358% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

OneMedNet has lower revenue, but higher earnings than Skillz. OneMedNet is trading at a lower price-to-earnings ratio than Skillz, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Skillz	$104.50M	1.33	-$70.41M	-$3.48	N/A
OneMedNet	$1.36M	29.83	-$2.80M	-$0.05	N/A

Summary

Skillz beats OneMedNet on 9 of the 15 factors compared between the two stocks.

How does OneMedNet compare to Resources Connection?

Resources Connection (NASDAQ:RGP) and OneMedNet (NASDAQ:ONMD) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Resources Connection has a net margin of -8.98% compared to OneMedNet's net margin of -254.13%. OneMedNet's return on equity of 0.00% beat Resources Connection's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Resources Connection	-8.98%	-4.63%	-3.16%
OneMedNet	-254.13%	N/A	-383.90%

93.2% of Resources Connection shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 7.9% of Resources Connection shares are held by insiders. Comparatively, 46.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

OneMedNet has lower revenue, but higher earnings than Resources Connection. OneMedNet is trading at a lower price-to-earnings ratio than Resources Connection, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Resources Connection	$452.01M	0.35	-$40.60M	-$1.20	N/A
OneMedNet	$1.36M	29.83	-$2.80M	-$0.05	N/A

Resources Connection has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, suggesting that its share price is 14% more volatile than the broader market.

Resources Connection currently has a consensus price target of $7.00, indicating a potential upside of 52.51%. Given Resources Connection's stronger consensus rating and higher possible upside, research analysts clearly believe Resources Connection is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Resources Connection	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Resources Connection had 8 more articles in the media than OneMedNet. MarketBeat recorded 10 mentions for Resources Connection and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.95 beat Resources Connection's score of -0.18 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Resources Connection	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Resources Connection beats OneMedNet on 9 of the 16 factors compared between the two stocks.

How does OneMedNet compare to OptimizeRx?

OneMedNet (NASDAQ:ONMD) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

OptimizeRx has a net margin of 6.37% compared to OneMedNet's net margin of -254.13%. OptimizeRx's return on equity of 10.86% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	-254.13%	N/A	-383.90%
OptimizeRx	6.37%	10.86%	7.93%

OneMedNet has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, indicating that its stock price is 8% more volatile than the broader market.

OptimizeRx has a consensus target price of $13.43, suggesting a potential upside of 96.04%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts clearly believe OptimizeRx is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

OptimizeRx has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.36M	29.83	-$2.80M	-$0.05	N/A
OptimizeRx	$109.43M	1.17	$5.13M	$0.35	19.57

1.0% of OneMedNet shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 46.2% of OneMedNet shares are held by insiders. Comparatively, 7.5% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, OptimizeRx had 1 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for OptimizeRx and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.95 beat OptimizeRx's score of 0.52 indicating that OneMedNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OptimizeRx beats OneMedNet on 12 of the 16 factors compared between the two stocks.

How does OneMedNet compare to comScore?

comScore (NASDAQ:SCOR) and OneMedNet (NASDAQ:ONMD) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

In the previous week, comScore and comScore both had 2 articles in the media. OneMedNet's average media sentiment score of 0.95 beat comScore's score of 0.06 indicating that OneMedNet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
comScore	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OneMedNet	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
comScore	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

comScore has a net margin of 24.81% compared to OneMedNet's net margin of -254.13%. comScore's return on equity of 230.75% beat OneMedNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
comScore	24.81%	230.75%	23.84%
OneMedNet	-254.13%	N/A	-383.90%

42.2% of comScore shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 3.1% of comScore shares are held by insiders. Comparatively, 46.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

comScore has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market.

OneMedNet has lower revenue, but higher earnings than comScore. OneMedNet is trading at a lower price-to-earnings ratio than comScore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
comScore	$357.47M	0.31	-$10M	$2.34	3.18
OneMedNet	$1.36M	29.83	-$2.80M	-$0.05	N/A

Summary

comScore beats OneMedNet on 9 of the 14 factors compared between the two stocks.

How does OneMedNet compare to MaxCyte?

OneMedNet (NASDAQ:ONMD) and MaxCyte (NASDAQ:MXCT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

MaxCyte has a consensus target price of $5.00, suggesting a potential upside of 350.45%. Given MaxCyte's stronger consensus rating and higher probable upside, analysts plainly believe MaxCyte is more favorable than OneMedNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OneMedNet	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
MaxCyte	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

1.0% of OneMedNet shares are owned by institutional investors. Comparatively, 68.8% of MaxCyte shares are owned by institutional investors. 46.2% of OneMedNet shares are owned by insiders. Comparatively, 4.1% of MaxCyte shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, OneMedNet had 2 more articles in the media than MaxCyte. MarketBeat recorded 2 mentions for OneMedNet and 0 mentions for MaxCyte. OneMedNet's average media sentiment score of 0.95 beat MaxCyte's score of 0.00 indicating that OneMedNet is being referred to more favorably in the media.

Company	Overall Sentiment
OneMedNet	Positive
MaxCyte	Neutral

OneMedNet has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, MaxCyte has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market.

OneMedNet has higher earnings, but lower revenue than MaxCyte. OneMedNet is trading at a lower price-to-earnings ratio than MaxCyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OneMedNet	$1.36M	29.83	-$2.80M	-$0.05	N/A
MaxCyte	$33.03M	3.60	-$44.63M	-$0.37	N/A

MaxCyte has a net margin of -121.16% compared to OneMedNet's net margin of -254.13%. OneMedNet's return on equity of 0.00% beat MaxCyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OneMedNet	-254.13%	N/A	-383.90%
MaxCyte	-121.16%	-20.03%	-17.14%

Summary

MaxCyte beats OneMedNet on 9 of the 16 factors compared between the two stocks.

Get OneMedNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ONMD vs. The Competition

Export

Metric	OneMedNet	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$40.57M	$1.45B	$6.80B	$13.02B
Dividend Yield	N/A	4.75%	2.60%	10.03%
P/E Ratio	-14.25	276.00	279.72	25.54
Price / Sales	29.83	63.91	648.71	115.96
Price / Cash	N/A	30.56	28.64	34.82
Price / Book	-11.87	4.84	11.12	6.36
Net Income	-$2.80M	-$25.90M	$3.48B	$347.58M
7 Day Performance	0.48%	1.24%	2.59%	3.17%
1 Month Performance	6.44%	-1.40%	-2.79%	-2.06%
1 Year Performance	44.50%	-19.22%	64.29%	21.19%

OneMedNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ONMD OneMedNet	1.2859 of 5 stars	$0.71 -6.2%	N/A	+57.5%	$40.57M	$1.36M	N/A	2
SKLZ Skillz	0.0583 of 5 stars	$8.90 +0.7%	$15.00 +68.5%	+32.4%	$138.93M	$104.50M	N/A	650	Upcoming Earnings Gap Down
RGP Resources Connection	3.4705 of 5 stars	$4.03 +1.6%	$7.00 +73.9%	-6.9%	$138.62M	$452.01M	N/A	3,055	Analyst Downgrade
OPRX OptimizeRx	4.5812 of 5 stars	$6.44 +1.6%	$13.43 +108.6%	-47.6%	$120.35M	$109.43M	18.33	100
SCOR comScore	1.0065 of 5 stars	$7.56 -1.5%	N/A	+29.7%	$114.01M	$357.47M	3.23	1,200	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ONMD) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OneMedNet (ONMD) Competitors